Type 1 Diabetes Trials: Transforming Research Into Treatments

We are proud to be a world leader in both type 1 diabetes prevention trials (in pre-diabetics, before the diagnosis of diabetes) and type 1 intervention trials (in newly diagnosed patients still in the “honeymoon period” with some degree of beta cell function). We also are a leading center conducting islet transplantation clinical trials.

Find Out If You or a Loved One May be Eligible for a Type 1 Diabetes Trial

Type 1 Diabetes Online Clinical Trials Screener

Screening for Relatives of People with Type 1 Diabetes

Relatives of People with Type 1 Diabetes: Age 1 to 45 Years – Antibody Screening

Prevention for Relatives of People with Type 1 Diabetes

Relatives of People with Type 1 Diabetes: Age 6 to 45 Years with a Normal OGTT and Positive for Two Antibodies

Relatives of People with Type 1 Diabetes: Age 8 to 45 Years with an Abnormal OGTT and Positive for Two Antibodies

Relatives of People with Type 1 Diabetes: Age 3 and Older – An Oral Insulin Prevention Study

Intervention for People with Type 1 Diabetes

Type 1 Diabetes: Age 18 to 60 Years – Living with Diabetes for Two or More Years (Bydureon)

Type 1 Diabetes: Age 18 to 45 Years – Within Three Months of Diabetes Diagnosis (Tocilizumab)

Type 1 Diabetes: People Age 18 to 70 Years Who Have Had a Kidney Transplant Greater Than Three Months Ago – Islet Cell Transplantation  

Type 1 Diabetes: Age 18 to 45 Years - Within Two Years of Diabetes Diagnosis (TILT)

 

 

 

 

 

 

 

 

 

 

 

 

For more information on our type 1 diabetes clinical trials, contact clinicalresearch@diabetes.ucsf.edu or call toll-free 844-T1D-UCSF (844-813-8273).